300636.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300636.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. The company is headquartered in Yichun, Jiangxi and currently employs 1,076 full-time employees. The company went IPO on 2017-03-31. The firm is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The firm's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The firm's products are sold to domestic and foreign markets, including Europe, North America and Japan.